Alcoholic cardiomyopathy: Incidence, clinical characteristics, and pathophysiology

Chest

Volumn 121, Issue 5, 2002, Pages 1638-1650

  Piano, Mariann R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alcohol; Cardiomyopathy; Contractile dysfunction; Heart failure

Indexed keywords

ALCOHOL; CALCIUM; CONTRACTILE PROTEIN; NEUROHORMONE; PRAZOSIN;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; CALCIUM HOMEOSTASIS; CARDIOVASCULAR RISK; CELL DEATH; CLINICAL FEATURE; DISEASE COURSE; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES;

EID: 0036246990     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5.1638     Document Type: Review

References (73)

1. Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
2. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
3. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy
4. Alcohol consumption idiopathic dilated cardiomyopathy: A case control study
5. Alcohol abuse and cardiomyopathy in men
6. Comparison of alcoholic cardiomyopathy in women versus men
7. Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure
8. Diastolic function impairment in alcoholics
9. Left ventricular filling impairment in asymptomatic chronic alcoholics
10. Early changes in left ventricular function in chronic asymptomatic alcoholics: Relation to the duration of heavy drinking
11. The heart in chronic alcoholism: A noninvasive study
12. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in young alcoholics
13. The effects of alcoholism on skeletal and cardiac muscle
14. What is moderate drinking?
15. Dilated cardiomyopathies: Changing pathophysiological concepts and mechanisms of dysfunction
16. Preclinical left ventricular abnormalities in alcoholic are independent of nutritional status, cirrhosis and cigarette smoking
17. Cardiovascular status in asymptomatic alcoholics, with reference to the level of ethanol consumption
18. Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics
19. Risk factors in alcoholic cardiomyopathy
20. Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic cardiomyopathy
21. Predication of recovery after abstinence in alcoholic cardiomyopathy: Role of hemodynamic and morphometric parameters
22. Consensus recommendations for the management of chronic heart failure
23. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men
24. Alcohol and breast cancer in women: A pooled analysis of cohort studies
25. Apoptosis: Basic mechanisms and implications for cardiovascular disease
26. Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: Partial basis for the fetal alcohol syndrome phenotype
27. Alcoholic cardiomyopathy: An electron microscopic study
28. Myocardial mechanical, biochemical and structural alterations induced by chronic ethanol ingestion in rats
29. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes
30. Cytoplasmic signaling pathways that regulate cardiac hypertrophy
31. Ethanol infusion increases ANP and p21 gene expression in isolated perfused rat heart
32. 2+ flux dysfunctions are reversible
33. Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart
34. Biochemical and contractile properties of heart muscle after prolonged alcohol administration
35. Electron microscopic observations in alcoholic heart muscle disease
36. Ultrastructural and histochemical observations in human and experimental alcoholic cardiomyopathy
37. Effect of prolonged alcohol administration on calcium transport in heart muscle of the dog
38. The effect of prolonged administration of ethanol on cardiac metabolism and performance in the dog
39. Myocardial metabolites of ethanol
40. Fatty acid ethyl esters potentially toxic products of myocardial ethanol metabolism
41. The acute and chronic effects of ethanol on cardiac muscle protein synthesis in the rat in vivo
42. Alcohol and the heart: Biochemical alterations
43. Molecular mechanisms of myocardial remodeling
44. Heavy long-term ethanol consumption induces an α- to β-myosin heavy chain isoforms transition in rat
45. 2+ transient
46. Effect of pimobenden and isoproterenol in the alcoholic myocardium
47. The preventive effect of verapamil on ethanol-induced cardiac depression: Phosphorus-31 nuclear magnetic resonance and high-pressure liquid chromatography studies of hamsters
48. 3H]nitrendipine in tissues from ethanol dependent rats
49. Effect of calcium, Bay K 8644 and reduced perfusion on basic indices of myocardial function in isolated hearts from rats after prolonged exposure to ethanol
50. Ethanol acutely and reversibly suppresses excitation-contraction coupling in cardiac myocytes
51. Ethanol inhibits electrically-induced calcium transients in isolated rat cardiomyocytes
52. Mechanism of myocardial contractile depression by clinical concentrations of ethanol
53. Contractile, metabolic and electrophysiologic effects of ethanol in the isolated rat heart
54. β-adrenergic receptor blockade in chronic heart failure
55. Cellular targets linked to cardiac remodeling in heart failure: Targets for pharmacologic intervention
56. Ethanol-induced cardiac hypertrophy: Correlation between development and the excretion of adrenal catecholamines
57. 1-adrenergic involvement in ethanol-induced cardiac hypertrophy
58. Metoprolol suppresses the development of ethanol-induced cardiac hypertrophy in the rat
59. Effect of chronic ethanol exposure on myocardial phosphoinositide turnover
60. A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography
61. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
62. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production
63. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis
64. Point mutation in mitochondrial DNA of patients with alcoholic cardiomyopathy
65. Alcoholism: An introduction
66. Screening for alcohol and drug abuse
67. The definition of alcoholism